• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型靶基因对雷公藤内酯醇抑制子宫内膜和卵巢癌细胞生长活性的响应。

Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.

机构信息

Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan.

出版信息

Cancer Lett. 2010 Nov 28;297(2):198-206. doi: 10.1016/j.canlet.2010.05.012. Epub 2010 Jun 14.

DOI:10.1016/j.canlet.2010.05.012
PMID:20547442
Abstract

Triptolide (TPL), a bioactive component of the Chinese medicinal herb Tripterygium wilfordii Hook F, induces apoptosis in some lines of human tumor cells. However, the effect of TPL on gynecologic cancer cells has not yet been well-described. We investigated the effects of TPL on cell growth, cell cycle, and apoptosis in endometrial and ovarian cancer cell lines. Furthermore, we examined global changes in gene expression after treatment with TPL. By using a list of 20 differentially expressed genes, Western blot analyses were performed on five endometrial and ovarian cancer cell lines. All cell lines were sensitive to the growth-inhibitory effect of TPL. TPL increased the proportion of cells in the S-phase of the cell cycle and induced apoptosis. cDNA microarray assay demonstrated that the treatment with TPL changed the expression of cell cycle regulators, apoptosis-related factors and cell proliferation markers. Of the gene expression changes induced by TPL treatment, up-regulation of LRAP, CDH4, and SFRP1 and down-regulation of cystatin, TNNT 1, and L1-CAM were confirmed using Western blot analysis in all the cell lines examined. We found a strong anticancer activity of TPL and identified some potential target genes of this drug, raising hopes that TPL may become a useful therapy for endometrial and ovarian cancers.

摘要

雷公藤内酯醇(TPL)是中药雷公藤的一种生物活性成分,可诱导某些人类肿瘤细胞凋亡。然而,TPL 对妇科癌症细胞的作用尚未得到很好的描述。我们研究了 TPL 对子宫内膜和卵巢癌细胞系的细胞生长、细胞周期和凋亡的影响。此外,我们还研究了 TPL 处理后基因表达的全局变化。通过使用 20 个差异表达基因列表,对五种子宫内膜和卵巢癌细胞系进行了 Western blot 分析。所有细胞系均对 TPL 的生长抑制作用敏感。TPL 增加了细胞周期 S 期的比例并诱导了细胞凋亡。cDNA 微阵列分析表明,TPL 处理改变了细胞周期调节剂、凋亡相关因子和细胞增殖标志物的表达。通过 Western blot 分析,在所有检测的细胞系中均证实了 TPL 处理诱导的基因表达变化,包括 LRAP、CDH4 和 SFRP1 的上调以及cystatin、TNNT1 和 L1-CAM 的下调。我们发现 TPL 具有很强的抗癌活性,并确定了该药物的一些潜在靶基因,这增加了 TPL 可能成为子宫内膜和卵巢癌有用治疗方法的希望。

相似文献

1
Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.新型靶基因对雷公藤内酯醇抑制子宫内膜和卵巢癌细胞生长活性的响应。
Cancer Lett. 2010 Nov 28;297(2):198-206. doi: 10.1016/j.canlet.2010.05.012. Epub 2010 Jun 14.
2
Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.蟾毒灵可诱导人子宫内膜癌细胞和卵巢癌细胞生长抑制、细胞周期阻滞及凋亡。
Int J Mol Med. 2008 May;21(5):637-43.
3
Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.β-羟基异戊酰紫草素对人子宫内膜癌细胞和卵巢癌细胞具有显著的抗增殖活性。
Gynecol Oncol. 2008 Apr;109(1):107-14. doi: 10.1016/j.ygyno.2007.12.020. Epub 2008 Jan 29.
4
Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.功能性p53是雷公藤内酯醇诱导胃癌细胞凋亡以及激活AP-1和核因子-κB所必需的。
Oncogene. 2001 Nov 29;20(55):8009-18. doi: 10.1038/sj.onc.1204981.
5
Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.芥酰磷胆碱在人子宫内膜癌细胞和卵巢癌细胞中表现出强大的抗生长活性。
Gynecol Oncol. 2008 Nov;111(2):336-43. doi: 10.1016/j.ygyno.2008.08.004. Epub 2008 Sep 13.
6
Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.雷公藤红素通过抑制细胞周期蛋白 E 和 CDC25A 诱导 S 期阻滞,并通过半胱天冬酶和线粒体依赖性信号通路在 A375.S2 人黑素瘤细胞中引发细胞凋亡。
Oncol Rep. 2013 Mar;29(3):1053-60. doi: 10.3892/or.2013.2230. Epub 2013 Jan 8.
7
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.一种新型组蛋白去乙酰化酶抑制剂司立他汀,可诱导人子宫内膜癌细胞和卵巢癌细胞生长抑制、细胞周期停滞及凋亡。
Int J Mol Med. 2006 Feb;17(2):323-9.
8
Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.雷公藤红素对两种人乳腺癌细胞系中 ERalpha 和 p53 表达的影响。
Phytomedicine. 2009 Nov;16(11):1006-13. doi: 10.1016/j.phymed.2009.03.021. Epub 2009 Jun 12.
9
Role of triptolide as an adjunct chemotherapy for ovarian cancer.雷公藤内酯醇作为卵巢癌辅助化疗药物的作用。
Chemotherapy. 2008;54(1):67-76. doi: 10.1159/000112419. Epub 2007 Dec 10.
10
Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.雷公藤红素通过下调 MDR1 表达抑制前列腺癌细胞的多药耐药性。
Neoplasma. 2013;60(6):598-604. doi: 10.4149/neo_2013_077.

引用本文的文献

1
Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer.雷公藤红素诱导铜死亡是治疗宫颈癌的一种新的抗肿瘤策略。
Cell Mol Biol Lett. 2024 Aug 28;29(1):113. doi: 10.1186/s11658-024-00623-4.
2
TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs.TPL通过靶向PI3K/AKT/NF-κB信号通路抑制M2型肿瘤相关巨噬细胞极化,从而抑制耐药性卵巢癌的侵袭和迁移。
Front Oncol. 2021 Jul 26;11:704001. doi: 10.3389/fonc.2021.704001. eCollection 2021.
3
Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells.
通过反向对接在卵巢癌细胞中发现雷公藤甲素的潜在靶点。
PeerJ. 2020 Mar 18;8:e8620. doi: 10.7717/peerj.8620. eCollection 2020.
4
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.转录组谱分析揭示了多个可能与乳腺癌相关的基因和细胞外基质受体相互作用途径。
Cell Mol Biol Lett. 2019 Jun 6;24:38. doi: 10.1186/s11658-019-0162-0. eCollection 2019.
5
Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response.雷公藤内酯醇通过 ROS/JNK 依赖性激活线粒体途径和抑制 Nrf2 介导的抗氧化反应诱导小鼠支持细胞凋亡。
Acta Pharmacol Sin. 2018 Feb;39(2):311-327. doi: 10.1038/aps.2017.95. Epub 2017 Sep 14.
6
Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3 platinum-resistant human ovarian cancer cells.雷公藤甲素可通过活性氧/核因子-κB途径避免顺铂耐药,并诱导SKOV3铂耐药人卵巢癌细胞凋亡。
Oncol Lett. 2013 Oct;6(4):1084-1092. doi: 10.3892/ol.2013.1524. Epub 2013 Aug 12.
7
Systems biology of meridians, acupoints, and chinese herbs in disease.经络、穴位和中草药在疾病中的系统生物学
Evid Based Complement Alternat Med. 2012;2012:372670. doi: 10.1155/2012/372670. Epub 2012 Oct 18.
8
Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum.基于预剂量基础血清内源性分子预测大鼠体内雷公藤红素的药代动力学参数。
PLoS One. 2012;7(8):e43389. doi: 10.1371/journal.pone.0043389. Epub 2012 Aug 17.
9
Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin.雷公藤内酯醇通过抑制基质金属蛋白酶 7 和 19 以及上调 E-钙黏蛋白抑制卵巢癌细胞侵袭。
Exp Mol Med. 2012 Nov 30;44(11):633-41. doi: 10.3858/emm.2012.44.11.072.
10
Anti-cancer natural products isolated from chinese medicinal herbs.从中药中分离得到的抗癌天然产物。
Chin Med. 2011 Jul 22;6(1):27. doi: 10.1186/1749-8546-6-27.